These date support a major involvement of miR-181b-medited TGFβR1 inactivation that drives down the TGF-β signaling and suppresses PI3K/Akt pathway in NSCLC proliferation and aggressiveness. The gene discussed is TGFBR1; the disease is non-small cell lung carcinoma.